The closing price of Allarity Therapeutics Inc (NASDAQ: ALLR) was $0.23 for the day, down -8.50% from the previous closing price of $0.25. In other words, the price has decreased by -$0.0210 from its previous closing price. On the day, 5105616 shares were traded.
Ratios:
Our analysis of ALLR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.14 and its Current Ratio is at 0.14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLR now has a Market Capitalization of 1.40M and an Enterprise Value of 4.28M.
Stock Price History:
Over the past 52 weeks, ALLR has reached a high of $154.40, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is 0.3769, while the 200-Day Moving Average is calculated to be 1.0422.
Shares Statistics:
ALLR traded an average of 181.74K shares per day over the past three months and 1.09M shares per day over the past ten days. A total of 5.89M shares are outstanding, with a floating share count of 5.49M. Insiders hold about 11.12% of the company’s shares, while institutions hold 0.94% stake in the company. Shares short for ALLR as of Mar 15, 2024 were 614.25k with a Short Ratio of 3.38, compared to 640.25k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.94% and a Short% of Float of 9.94%.
Earnings Estimates
The firm’s stock currently is rated by 1 analysts. On average, analysts expect EPS of -$0.53 for the current quarter, with a high estimate of -$0.53 and a low estimate of -$0.53, while EPS last year was -$177.2. The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.28 and low estimates of -$0.28.
Analysts are recommending an EPS of between -$1.43 and -$1.43 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$1.52, with 1 analysts recommending between -$1.52 and -$1.52.
